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Summary
The determination of enzyme activity or inhibition in
intact living cells is a problem in the development of
inhibitors for intracellular proteases. The production
of fluorescent protoporphyrin IX (PpIX) from the non-
fluorescent (N)-Gly/Pro-5-aminolevulinic acid (ALA)
substrates was used to evaluate the prolyl/glycyl-spe-
cific dipeptidylpeptidase IV (DPPIV)-like and prolyloli-
gopeptidase (POP)-like activities of human cells. The
results demonstrated that whereas POP-like activity
could be attributed to the actual POP, the DPPIV-like
activity could be related to actual DPPIV only in one
colon cell line. In the other breast and colon cell lines,
DPPIV-like activity was intracellular and displayed by
other prolyl-specific aminopeptidases. Our experiments
also demonstrated the involvement of gylcyl-specific
proteases in the processing of ALA precursors.
These observations have important consequences
for the development and evaluation of selective inhib-
itors for these enzymes.
Introduction
Proteases are major targets in the treatment of human
diseases. However, although there has been much suc-
cess with drugs developed for inhibiting extracellular
proteases (either secreted or inserted in the outer cell
membrane), the inhibition of intracellular proteases,
and the evaluation of this inhibition, in intact living cells
is difficult to achieve due to the limitation of membrane
permeability of protease substrates or inhibitors. It is
becoming increasingly accepted that intracellular pro-
teases are important targets for drug development;
thus, it is necessary to develop tools for evaluating the
effects of inhibitors in the intracellular environment of
these enzymes. Most present approaches, however, in-
volve cell lysis, thus losing important information on the
state of living cells.
Many biologically active peptides are protected from
general proteolytic degradation by evolutionarily con-
served Pro. This protection is provided due to confor-*Correspondence: lucienne.juillerat@chuv.hospvd.chmational constraints imposed by the Pro residue, point-
ing to the biological importance of this amino acid.
Therefore, inhibitors of prolyl-specific peptidases have
a high potential for drug discovery. Of the approxi-
mately 400 known human proteases, only a few Pro-
specific proteases have been described [1–6]. Dipepti-
dylpeptidase IV (DPPIV)/CD26 (EC 3.4.14.5.) is a widely
expressed dimeric type II integral membrane protein re-
leasing X-Pro dipeptides from the free N-terminal se-
quence of peptides. Nearly all peptides and proteins
bearing an X-P sequence are potential substrates for
DPPIV [4], and inhibitors for this enzyme are under clin-
ical evaluation for the treatment of type 2 diabetes. Fi-
broblast activation protease α (FAPα)/seprase is a di-
meric type II integral membrane prolyl dipeptidase
found in remodeling tissue, with an enzymatic activity
comparable to DPPIV. Quiescent cell proline dipepti-
dase (QPP)/DPPII/DPP7 (EC 3.4.14.2) is a homodimeric
glycoprotein located in intracellular vesicles, with spe-
cificity and serine protease characteristics identical to
DPPIV [7]. DPP8 and DPP9 are recently described
monomeric, ubiquitously expressed, soluble, and cyto-
solic DPPIV-like enzymes of roughly 100 kDa, without a
transmembrane domain [8, 9]. Of the Pro-specific DPP
family, only DPP8 and DPP9 are exclusively cytoplas-
mic, and only DPPIV, FAPα, DPP8, and DPP9 have en-
zymatic activities. All these enzymes need a free N-ter-
minal aminoacid. Prolyl oligopeptidase (POP) (EC 3.4.21.
26.) is an intracellular, much conserved, and widely dis-
tributed soluble and cytosolic post-prolyl-endopepti-
dase of 80 kDa [5]. The interest in this enzyme has
increased since it has been demonstrated that POP in-
hibitors ameliorate cognitive disorders [1–6]. The 3D
structure and kinetic characteristics of DPPIV and POP
have been determined [5]. From this information, sev-
eral families of inhibitors have been synthesized and
evaluated on purified enzymes [10–12] and their effects
determined in a few biological models, suggesting the
inhibition of families of enzymes with similar activity.
Therefore, it is necessary to develop methods that
will allow researchers to differentiate between the activ-
ities of the cytoplasmic and membrane forms of these
enzymes in order to asses the cellular effects of inhibi-
tors. We have previously shown that pseudopeptide
derivatives of 5-aminolevulinic acid (ALA) are sub-
strates for selected proteases that release free ALA
from the derivatives; the free ALA is metabolized by liv-
ing cells to the fluorescent protoporphyrin IX (PpIX) re-
tained inside cells [13, 14]. Thus, intracellular accumu-
lation of the fluorescent PpIX following administration
to cells of nonfluorescent peptide derivatives of ALA is
an indicator of the cellular expression and/or activity of
these proteases. Specifically, we have shown that Pro/
Gly derivatives can be substrates for cellular proteases.
We reasoned that such substrates can be used as a
potential reporting system for the kinetic determination
of the cellular level of proteolytic activity in living intact
cells. In this article, we validate such a concept us-
ing prolyl/glycyl-specific amino dipeptidase-like (DPPIV-
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868Figure 1. Scheme: Chemical Syntheses
Reagents: (i) P2O5, PO(OC2H5)2, NEt3, 100°C,
2 hr; (ii) HCl/MeOH 1.25 M, H2, MeOH, Pd/C,
RT, 4 hr.like) and endopeptidase-like (POP-like) activities in hu-
man breast and colon cancer cells.
Results and Discussion
To evaluate cellular enzymatic activities, most methods
rely on fluorogenic substrates, such as amido-4-methyl-
coumarin derivatives in lysates of tissues or cells. These
approaches allow for determining overall levels of enzy-
matic activity and inhibition, but do not provide infor-
mation on enzyme activity, or residual activity, in a living
cell. To some degree, these drawbacks can be over-
come by using histoenzymography on tissue sections
or fixed cell layers, such as the red precipitates ob-
tained following the release of methoxy-2-naphthyla-
mine from peptide substrates in the presence of a di-
azotating reagent [13]. However, for most intracellular
proteases, these assays cannot generally be performed
in nonpermeabilized living cells. We have previously
shown [13, 14] that peptide-ALA derivatives are first in-
ternalized into cells using an ALA transport system;
then, ALA is proteolitically released from its peptide
carrier to produce the fluorescent PpIX via the heme
synthetic pathway. Thus, the production of PpIX from
ALA precursor derivatives may be used as a reporter
system for the kinetic determination of the cytoplasmic
processing of a peptide by proteolytic enzymes. Here
we compared actual PpIX production in human carci-
noma cells exposed to Gly/Pro-containing dipeptide-
ALA derivatives with proteolytic activity obtained using
standard substrates in intact living cells or in cell ex-
tracts.
The synthesis and characterization of the N-protected
and N-deprotected dipeptide derivatives of 5-ALA has
been previously described [13, 14]. To synthesize (see
the Supplemental Data available with this article online)
the 4-methyl-coumaryl-7-amide (AMC) and 4-methoxy-
β-naphtylamide (β-NA) Gly derivatives, which are not
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iommercially available, we used a modification of the
hosphorus pentoxide method of Schramm and Wiss-
an [15, 16], in which the amine is activated as a phos-
horamide monoethyl ester and then coupled with a
arboxylic acid to yield a carboxamide (Figure 1, Table
1). An initial attempt, using cyclohexylcarbodiimide as
he coupling agent, failed to yield any product (data
ot shown).
First we determined whether human surgical sam-
les and cells in culture demonstrated DPPIV-like and
OP-like activities. Histological slides of frozen human
urgical tissue were exposed to substrates specific for
PPIV-like (Gly-Pro-β-NA) or POP-like (Z-Gly-Pro-β-NA)
eptidases (Figure 2A; DPPIV-like activity in nontumoral
nd tumoral human colon). In normal human colon,
PPIV-like activity was expressed along, but not at the
ips of, the crypts. In human colon cancer, only a few
umoral cells expressed this activity, suggesting hetero-
eneous expression of DPPIV-like activity by human
ancer. POP-like and post-Gly-cleaving activities were
ever found using such an approach (data not shown).
o study these activities in more detail, we selected two
uman colon (SW480 and HT-29) and two human breast
T47D and MCF-7) carcinoma cell lines. Human colon and
reast carcinoma cells expressed the mRNAs for DPPIV,
APα, and POP (Figure 2B), as observed using RT-PCR
nd pairs of primers (Table S2) selective for POP, DPPIV,
nd FAPα. Extracts of human colon and breast carci-
oma cells hydrolyzed the fluorogenic Z-Gly-Pro-AMC
POP-like) and Gly-Pro-AMC (DPPIV-like) substrates
Figure 2C). Z-Gly-Gly-AMC was never hydrolyzed,
hereas Gly-Gly-AMC was hydrolyzed at very low
evels only by SW480 and T47D cell extracts (Figure
C). Only HT-29 colon carcinoma cells expressed
PPIV-like activity using zymography of cells extracts
Figure 2D). POP-like activity was never detected using
ymography, suggesting that the zymography process
nactivates this enzyme. Western blotting experiments
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869demonstrated that only HT-29 cells expressed actual
DPPIV protein (Figure 2E), corresponding to the zymog-
raphy experiments. As expected, FAPα was not ex-
pressed by all cancer cell lines, but by primary human
fibroblasts in culture used as positive control cells (re-
sults not shown). We performed gel filtration experi-
ments using SW480, HT-29, T47D, and MCF-7 cell ex-
tracts (data not shown). In all cells, DPPIV-like activities
eluted at approximately 200 kDa and POP-like activity
at approximately 80 kDa, which corresponded to the
expected value of the molecular weight for these fami-
lies of enzymes.
We then compared the AMC-hydrolyzing activities in
intact cells (Figure 3, right panels) with PpIX production
(Figure 3, left panels) from precursors with similar
amino acid substitution. Only Z-Gly-Pro-AMC (POP-like
activity) was rapidly hydrolyzed by all intact cells,
whereas cell extracts (Figure 2C) hydrolyzed Gly-Pro-Figure 2. Determination of Prolyl-Specific
Peptidases in Human Tissue and Cells
(A) Histoenzymography: Frozen histological
slides of either human normal colon or colon
cancer were exposed to Gly-Pro-β-Methoxy-
naphthylamide and Fast Blue B. Cells ex-
pressing the enzyme activity are localized by
a red precipitate.
(B) RT-PCR: RNA was extracted from SW480,
HT-29, T47D, and MCF-7 cells and subjected
to RT-PCR amplification using primers shown
in Table S2.
(C) Enzymatic activities: Human carcinoma
cell extracts were exposed to AMC sub-
strates and increase in fluorescence was re-
corded. Open circles, Z-Gly-Gly-AMC; open
diamonds, Z-Gly-Pro-AMC; closed circles,
Gly-Gly-AMC; closed diamonds, Gly-Pro-AMC.
(D) Zymography: Cells were extracted in
PBS-Triton and subjected to electrophore-
sis, then exposed to Gly-Pro-β-methoxy-
naphthylamide and Fast Blue B.
(E) Western blotting: Cells were extracted in
PBS-Triton and subjected to electrophore-
sis, then exposed to anti-human DPPIV an-
tibody.AMC (DPPIV-like activity) and Z-Gly-Pro-AMC with com-
parable equipotency. These results suggested either
that POP-like enzyme(s) were expressed at the cell sur-
face or that the substrate was rapidly transported
across the cell membrane, whereas DPPIV-like activity
was not accessible to a substrate added extracellularly.
Z-Gly-Gly-AMC and Gly-Gly-AMC were not hydrolyzed
by intact cells. Boc-Gly-Pro-ALA was hydrolyzed by all
cells. SW480 and T47D cells hydrolyzed Boc-Gly-Gly-
ALA and Gly-Pro-ALA more efficiently than HT-29 and
MCF-7 cells. None of the cell lines hydrolyzed Gly-Gly-
AMC. Thus, protease activities measured in intact cells
with AMC substrates did not correlate with actual PpIX
production from the ALA derivatives, whereas DPPIV-
like and POP-like activities in cell extracts (as deter-
mined from data presented in Figures 1C) and PpIX pro-
duction were correlated (Figure 3; for correlations and
Figure S1, see the Supplemental Data). This information
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870suggests that the proteolytic activities involved in the
hydrolysis of precursors located intracellularly rather
than at the cell surface, and that Gly-hydrolyzing activi-
ties participate in the proteolytic processes and are
predictive of intracellular proteolysis of Gly/Pro sub-
strates.
Finally, from the data presented in Figure 3 (left pan-
els), we calculated the overall kinetic enzymatic char-
acteristics (“overall KM ”) (Table S3) of PpIX production
in the four cell lines exposed to the various (N)-Gly/Pro-
ALA precursors (Figure 3). Overall KM was determined
using an adaptation of the Lineweaver and Burke
double-reciprocal plot for the determination of enzy-
matic kinetic constants. Cells were exposed to increas-
ing concentrations of ALA or the various Gly/Pro-ALA
derivatives and steady-state fluorescence increase was
used to draw double-reciprocal plots of 1/increase in
fluorescence versus 1/concentration of ALA derivative
added to cells and KM values calculated from the plots.
The results showed that, whereas the amount of PpIX
produced by cells may be different, the overall KM val-
ues were generally comparable for one given precursor,
suggesting that the amount of PpIX production depended
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cFigure 3. PpIX Production in Intact Human
Carcinoma Cells Exposed to Pro/Gly-ALA-
Derivatives. Comparison with Post-Pro/Gly-
AMC Cleaving Activities in Intact Cells
Left panels: PpIX production. Cells were
grown to confluence and exposed to either
ALA used as a standard molecule for PpIX
production, or dipeptide Gly/Pro-ALA deriva-
tives. PpIX production was determined by
continuous recording of increase in PpIX
fluorescence. SW480 and HT 29 cells: closed
squares, ALA (4 mM); open circles, Boc-Gly-
Gly-ALA-OEt (1.35 mM); closed circles, Gly-
Gly-ALA-OEt (1.65 mM); open diamonds,
Boc-Gly-Pro-ALA-OEt (1.9 mM); closed dia-
monds, Gly-Pro-ALA-OEt (1.6 mM).
MCF-7 and T47D: closed squares, ALA (0.67
mM); open circles, Boc-Gly-Gly-ALA-OEt
(0.64 mM); closed circles, Gly-Gly-ALA-OEt
(0.8 mM); open diamonds, Boc-Gly-Pro-ALA-
OEt (0.9 mM); closed diamonds, Gly-Pro-
ALA-OEt (0.82 mM).
Right panels: AMC-cleaving activities. Colon
(HT-29, SW480) or breast (MCF-7, T47D) car-
cinoma cells were grown to confluence and
intact living cells were exposed to dipeptide
Gly/Pro-AMC substrates. AMC release was
determined by continuous recording of in-
crease in AMC fluorescence. Open circles,
Z-Gly-Gly-AMC; open diamonds, Z-Gly-Pro-
AMC; closed circles, Gly-Gly-AMC; closed
diamonds, Gly-Pro-AMC.
Correlations: Comparison of the correlation
coefficients (R) between enzymatic activities
measured by hydrolysis of AMC derivatives
(fluorescence AMC/20 min) in intact living
cells (intact cells), in cell extracts (cell ex-
tracts) and PpIX production measured as
PPIX fluorescence at 300 min (Figure S1).
For calculation of the correlation coeffi-
cients, the initial enzymatic rates (fluores-
cence AMC/20 min) either in intact living
cells or in cell extracts, and PPIX production
(PPIX fluorescence at 300 min) were corre-
lated for each cell line studied.nly on the cellular internalization of the precursor and/
r hydrolytic release of ALA by the appropriate prote-
se; cellular PpIX synthesis from proteolytically re-
eased ALA was comparable in all cells.
In conclusion, our results suggest that POP-like activ-
ty corresponds to actual intracellular POP. Both Z-Gly-
ro-AMC and Z-Gly-Pro-ALA precursors provided iden-
ical information, indicating that they can be rapidly
ransported across the cell membrane. The identity of
he DPPIV-like activities is more difficult to ascertain.
PPIV-like activity can be attributed to actual DPPIV
nly in HT-29 cells, because only these cells expressed
PPIV mRNA, protein (measured by western blotting),
ctivity (measured by fluorometry and zymography),
nd molecular weight (determined by gel filtration) cor-
esponding to DPPIV. Because FAPα protein was not
xpressed in these cells, this enzyme can be excluded;
el filtration excluded DPP8 and DPP9, which have
ower molecular weights than DPPIV or FAPα. Interest-
ngly, our experiments also demonstrated, particularly
n SW480 and T47D cells, the involvement of post-Gly-
leaving activities in the cellular processing of ALA pre-
ursors that were not detected using AMC precursors.
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871Significance
Inhibitors for post-Pro-cleaving peptidases, such as
DPPIV-like and POP-like peptidases, have been devel-
oped as potential therapeutically useful drugs in the
treatment of various human diseases. However, the
observation that ubiquitously expressed enzymes in
various subcellular locations and with comparable
enzymatic activities may be inhibited by these pepti-
dases raises the question of the exact site, mode of
action, and biological target(s) of these inhibitors. We
demonstrate here the potential of Gly/Pro-ALA-deriv-
atives as a reporter system to evaluate the activity
and inhibition of post-Pro and post-Gly peptidases in
intact, living human cells. Importantly, our results in-
dicate that although cell membrane DPPIV was the
main enzyme postulated in the processing of bioac-
tive peptides and the target of inhibitor development,
it is necessary to consider intracellular activity of
peptidases with comparable specificity and kinetic
characteristics in the evaluation of such inhibitors.
Our results with ALA derivatives do not suggest the
involvement of activities other than those of POP en-
zyme; however, DPPIV-like peptidases other than ac-
tual DPPIV were mainly involved in the processing of
these Pro drugs.
Experimental Procedures
Syntheses
Procedures for the preparation and characterization of the 7-amino-
4-methylcoumarin and 4-methoxy-β-naphtylamine ALA peptide an-
alogs are outlined in Figure 1 and described in detail in the Supple-
mental Data.
Biological Approaches: Cells and Culture Conditions
Human colon HT29 and SW480 or breast T47D and MCF-7 carci-
noma cell lines were from the ATCC (American Type Culture Collec-
tion, Manassas, VA), and treated as previously described [13, 14].
Human primary fibroblasts were obtained from cultures of human
surgical specimens using the explant technique.
RT-PCR Experiments
Total RNA from confluent cells was prepared using Trizol reagent
(GIBCO-BRL, Basel, Switzerland) and RT-PCR for DPPIV, FAP, and
POP was performed according to standard procedures and spe-
cific primers, the sequence and size of transcripts of which are
described in Table S2.
PpIX Fluorescence Measurements
Evaluation of PpIX production in living cells by continuous fluores-
cence recording was essentially performed as previously described
[13, 14]. Experiments were repeated at least twice and were per-
formed in sextuple wells. Means of results ± SD were calculated.
Correlation coefficients were calculated using a two-tailed paired
Student’s t test.
Peptidase Activities
Peptidase activities were determined using AMC substrates (com-
mercially available from Bachem, Bubendorf, Switzerland, or cus-
tom synthesized) either in intact living cells in DMEM medium with-
out phenol red and FCS (GIBCO), or in cell extracts obtained in
PBS-0.1% Triton X-100 (Fluka, Buchs, Switzerland). Increase in
fluorescence was continuously recorded for 30–60 min at 37°C
in a fluorescence multiwell plate reader (CytoFluor Series 4000;
PerSeptive Biosystems, Framingham, MA; λex: 360 nm; λem: 460
nm). Experiments were repeated at least twice and were performed
in sextuple wells. Means of results ± SD or correlation coefficients
were calculated.In Situ Enzymatic Activity Determination—
Cyto/Histoenzymography
The experiments were essentially performed as previously de-
scribed [13] using peptide-β-methoxynaphthyl-amide (β-NA) deriv-
atives (Bachem or custom synthesized) using 5 m sections of fro-
zen tissue. The presence of enzymatic activity is visualized as a
red precipitate.
Zymography and Western Blotting Experiments
Cells were extracted in 0.05 M Tris, 0.15 M NaCl, 2 mM EDTA,
0.01% Triton X-100 (pH 7.2). Protein content was determined using
the BCA kit (Pierce, Socochim, Switzerland), after which 60, 40, or
20 g for zymography, or 30 g for Western blotting, of protein was
separated on a 7.5% acrylamide gel containing 0.1% SDS, without
prior denaturation and without β-mercaptoethanol, and then trans-
ferred onto a nitrocellulose membrane (Scleicher and Schuell, Das-
sel, Germany). For the zymography experiments, membranes were
exposed to either Z-Gly-Pro-β-methoxy-naphthylamide or Gly-Pro-
β-methoxy-naphthylamide (2.2 mM final concentration) and 2.3 mM
Fast Blue B (Fluka) for 5 hr in a humidified chamber at 37°C. For
the Western blotting experiments, membranes were exposed to the
anti-human DPPIV monoclonal antibody (clone 2A6, eBioscience,
San Diego, CA) or anti-human FAP (BenderMedSystems, Inc., Bur-
lingame, CA; Code BMS168) and peroxydase-anti-mouse second-
ary antibody and ECL detection (Amersham Biosciences, Little
Chalfont, UK) were performed.
Supplemental Data
Supplemental Data, including additional Experimental Procedures,
three tables, and one figure, are available at http://www.chembiol.
com/cgi/content/full/12/8/867/DC1/.
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